First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial

作者：Xiaopeng Tian, Jun Cai, Yi Xia, Yuchen Zhang, Liang Wang, Panpan Liu, Huiqiang Huang, Yajun Li, Hui Zhou, Zhiming Li, H. J. Yang, Liqiang Wei, Qi-Hua Zou, Ying Huang, Jun Li, Ling Li, Wen-Long Zhong, Qingqing Cai · 发表于：The Lancet Haematology · 年份：2024 · DOI：10.1016/s2352-3026(24)00066-8 · 被引用次数：33 · 研究领域：Lymphoma Diagnosis and Treatment、Head and Neck Cancer Studies、Immune Cell Function and Interaction